Suffolk Breast Imaging adds CureMetrix AI for mammogram calcification detection

Suffolk Breast Imaging in Lake Grove, New York, has added CureMetrix's cmAngio AI to routine screening mammography to detect and localize breast arterial calcification from the same exam used for breast cancer screening. The move is aimed at giving radiologists more clinical insight without extra imaging, radiation or workflow changes.

Why it matters: - Suffolk Breast Imaging is using AI to extract more clinical value from routine mammograms without asking patients to do anything extra. - cmAngio adds breast arterial calcification detection to screening exams, which can give radiologists another data point from an exam women already receive. - The integration is designed to fit into existing mammography workflows, which can make adoption easier for imaging practices.

What happened: - CureMetrix announced that Suffolk Breast Imaging has added cmAngio, the first FDA-cleared AI solution for breast arterial calcification detection and localization, to its breast imaging services. - Suffolk Breast Imaging has served Suffolk County, Long Island since 1985. - The practice is based in Lake Grove, New York. - Dr. Alexandra Perkins said the addition is meant to provide additional clinical insight from screening mammograms while keeping the practice's personalized care model.

The details: - cmAngio identifies breast arterial calcification from the same mammogram used for breast cancer screening. - The AI tool does not require additional imaging, radiation, appointments or changes to standard mammography workflows. - Suffolk Breast Imaging offers screening and diagnostic mammography, breast ultrasound, image-guided breast biopsy and bone density testing. - The practice says it continues to invest in advanced AI technologies to support radiologists and patients during the screening experience. - CureMetrix said it is expanding access to cmAngio through partnerships with practices that share its focus on innovation and patient care. - CureMetrix was founded in 2014 and focuses on AI-powered imaging tools for women's health.

Between the lines: - The deal reflects a broader push to make routine breast imaging more informative without increasing friction for patients or providers. - AI features that work inside existing workflows are more likely to be adopted by community imaging practices than tools that require separate visits or new procedures. - Suffolk Breast Imaging is positioning technology as an extension of its patient-centered brand, not a replacement for human expertise.

What's next: - Suffolk Breast Imaging is likely to use cmAngio as part of its ongoing effort to modernize breast imaging services. - CureMetrix said it will keep expanding access to cmAngio through additional practice partnerships. - Both companies are betting that more value can be delivered from the mammograms women already receive each year.

The bottom line: - The partnership turns a routine mammogram into a broader screening tool, with no added scan or appointment for patients.